General Partner, Lightstone Ventures
Mike is a General partner and Team Leader of Lightstone Ventures (LSV) and focuses on investments in the biopharmaceutical and medical device sectors. He is based in the firm’s Palo Alto, CA office, where he also serves as a general Partner at Advanced Technology Ventures (ATV). His representative investments include Altura Medical, Ardian (acquired by Medtronic), EndoGastric solutions, GI Dynamics (ASX: GID), Holaira, MicroVention (acquired by Terumo), Plexxikon (acquired by Daiichi Sankyo), PowerVision, Second Genome, and TranS1 (NASDAQ: TSON).
Featured on the Forbes Midas List of top technology and life science investors, Mike is a recognized thought leader in the industry and a frequest spaker at healthcare conferences. He serves as a Lecturer at the Amos Tuck School of Business Administration at Dartmouth College where he also sits on the Tuck MBA Advisory Board. Previously, Mike was a faculty member of the Stanford Biodesign Emergining Entrepreneurs Forum and an advisory board member to the UCSF/Berkeley Venture Innovation Program.
Earlier in his career, Mike served as the Director of Business Development for Inhal Therapeutic Systems (now Nektar Therapeutics, NASDAQ: NKTR), a venture-backed pulmonary drug delivery company that went public in 1994. At inhale, Mike led partnering activities with a number of pharmaceutical and biotechnology companies in the U.S., Europe, and Japan. Mike also was a Principal at The Wilkerson Group, a leading management consulting firm focused exclusively on healthcare. At The Wilkerson Group, Mike helped establish the firm’s offices in London and San Francisco.